Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Blog updated 12/22/2022
Blog updated 12/22/2022
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 04/07/2023
Access these tools on integrating hepatitis screening and treatment within HIV care programs.
Blog updated 05/20/2024
Monographs describing interventions for the engagement and retention of Latinos in HIV care.
Resource updated 09/20/2021
Blog updated 03/28/2024